Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
10/18/2007
 
First Published:
4/23/2005
1.
Phase II Study of Caspofungin Acetate as First-Line Therapy for Proven or Probable Invasive Aspergillosis in Patients With Hematologic Malignancies or in Patients Who Have Undergone Hematopoietic Stem Cell Transplantation
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Active
18 and over
Other
EORTC-65041
EUDRACT-2004-002944-90, NCT00110045
Last Modified:
10/23/2007
 
First Published:
10/7/2005
2.
Phase II Study of Voriconazole and Caspofungin Acetate in Immunocompromised Patients With Invasive Fungal Infections
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Active
18 and over
NCI
OHSU-HEM-0346-L
OHSU-IRB-1379, NCT00238355
3.
Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Active
18 and over
Other
Uni-Koeln-687
EudraCT- No.: 2006-001936-30, NCT00404092
4.
Prophylaxis of Fungal Invasive Infections in Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Active
18 and over
Other
2006-004432-70
NCT00501098
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute